LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 7.77 | 84.90 | 935 | 411 | 2.2736 | 1.8691 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 9.47 | 84.90 | 1 | 447 | 0.0022 | -0.8431 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 9.47 | 84.90 | 809 | 447 | 1.8081 | 1.5604 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 9.47 | 84.90 | 1 | 447 | 0.0022 | -0.8431 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 9.47 | 84.90 | 1021 | 447 | 2.2819 | 1.8213 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 11.18 | 84.90 | 4 | 492 | 0.0081 | -0.7002 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 11.18 | 84.90 | 852 | 492 | 1.7305 | 1.4828 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 11.18 | 84.90 | 1 | 492 | 0.0020 | -0.8265 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 11.18 | 84.90 | 1102 | 492 | 2.2382 | 1.7479 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 12.88 | 84.90 | 14 | 531 | 0.0264 | -0.4941 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 12.88 | 84.90 | 843 | 531 | 1.5876 | 1.3819 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 12.88 | 84.90 | 8 | 531 | 0.0151 | -0.5906 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 12.88 | 84.90 | 1100 | 531 | 2.0716 | 1.6340 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 14.58 | 84.90 | 113 | 663 | 0.1703 | 0.1012 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 14.58 | 84.90 | 882 | 663 | 1.3295 | 1.2016 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 14.58 | 84.90 | 209 | 663 | 0.3150 | 0.3549 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 14.58 | 84.90 | 1231 | 663 | 1.8556 | 1.4635 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 16.29 | 84.90 | 530 | 766 | 0.6911 | 0.7803 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 16.29 | 84.90 | 967 | 766 | 1.2610 | 1.1515 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 16.29 | 84.90 | 464 | 766 | 0.6051 | 0.7073 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 16.29 | 84.90 | 1203 | 766 | 1.5687 | 1.3047 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 17.99 | 84.90 | 644 | 898 | 0.7164 | 0.8133 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 17.99 | 84.90 | 910 | 898 | 1.0123 | 1.0072 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 17.99 | 84.90 | 579 | 898 | 0.6441 | 0.7576 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 17.99 | 84.90 | 1197 | 898 | 1.3315 | 1.1755 | MN20160318_Q02 | I05 |